Book a meeting
DO-BO

What are the latest trends in Turkish Healthcare Market Access, Oznur Seyhun?

Join us on the latest episode of MAP – the Market Access Podcast – hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management.

Explore the latest trends in healthcare market access in Turkey, and discover how they are adapting to economic challenges like inflation and currency fluctuations. Learn about the introduction of Multi-Criteria Decision Analysis (MCDA) in reimbursement submissions, the rise of digital health solutions, and patient support programs.

This episode is for anyone looking to deepen their understanding of why Turkey remains an attractive market for pharmaceutical companies despite economic pressures, with insights into local manufacturing incentives and the evolving private sector.

Tune in to gain a comprehensive understanding of the current landscape and future prospects of market access in Turkey. Don’t miss out on this insightful discussion!

Related

Why Should Pharma and MedTech Innovators Look at New Zealand, Julius Ohrnberger?

By

Stefan Walzer

Tune in to this new episode of MAP to explore New Zealand’s unique healthcare and reimbursement landscape with Dr. Stefan Walzer and health economist Dr. Julius Ohnberger. Learn how PHARMAC combines HTA and payer roles, why equity and Māori health outcomes are central to market access and what global pharma can gain from launching in […]

Are We Ready for a Cultural Shift Toward AI in Pharma, Elizabeth Shanahan?

By

Stefan Walzer

In this brand new episode of MAP – the Market Access Podcast, Dr. Stefan Walzer sits down with Elizabeth Shanahan, AI Strategy Lead at Sanofi, for a refreshingly honest conversation on the real-world implementation of artificial intelligence in pricing, evidence generation, and HTA processes. From streamlining evidence generation to enhancing pricing strategies and dossier creation, […]

What Can Europe and the U.S. Learn from Each Other on Market Access, Anne Loos?

By

Stefan Walzer

Tune in to this new episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer is joined by Anne Loos from Wickenstones, to explore the evolving landscape of U.S. market access and reimbursement. The U.S. reimbursement landscape is changing — driven by AI, global influences with the European JCA and political programs such as […]